[Federal Register Volume 65, Number 80 (Tuesday, April 25, 2000)]
[Notices]
[Page 24233]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-10256]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (NeoPharm, Inc., Common Stock, Par Value $.0002145 
Per Share) File No. 1-12493

April 19, 2000.
    NeoPharm, Inc. (``Company'') has filed an application with the 
Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') \1\ and 
Rule 12d2-2(d) thereunder,\2\ to withdraw the security described above 
(``Security'') from listing and registration on the American Stock 
Exchange LLC (``Amex'') and under Section 12(b) of the Act.\3\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
    \3\ 15 U.S.C. 78l(b).
---------------------------------------------------------------------------

    The Company, whose business is biotechnology, has determined to 
transfer trading in its Security from the Amex to the National Market 
of the Nasdaq Stock Market, Inc. (``Nasdaq''), which it considers to be 
the preeminent marketplace for the securities of biotechnology 
companies. The Company has registered its Security pursuant to Section 
12(g) of the Act \4\ by filing a Registration Statement on Form 8-A 
with the Commission on April 12, 2000. The Security subsequently became 
designated for quotation and began trading on the Nasdaq National 
Market, and was simultaneously suspended from trading on the Amex, on 
April 14, 2000.
---------------------------------------------------------------------------

    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    The Company has stated that it has complied with the Rules of the 
Amex governing the withdrawal of its Security from listing and 
registration on the Exchange and that the Amex, in turn, has indicated 
that it will not oppose such withdrawal.
    The Company's application relates solely to the withdrawal of the 
Security from listing and registration on the Amex and shall have no 
effect upon the Security's designation for quotation and trading on the 
Nasdaq National Market and registration under Section 12(g) of the 
Act.\5\
---------------------------------------------------------------------------

    \5\ Id.
---------------------------------------------------------------------------

    Any interested person may, on or before May 10, 2000, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW, Washington, DC 20549-0609, facts bearing upon whether 
the application has been made in accordance with the rules of the Amex 
and what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\6\
---------------------------------------------------------------------------

    \6\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 00-10256 Filed 4-24-00; 8:45 am]
BILLING CODE 8010-01-M